mail
versión imprimible
 
 

Gene Therapy for Muscular Disorders

Evvnt Promotion / evvnt
-
21.02.2023 - 23.02.2023  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, USA
Time: 9:30 am to 4:30 pm
 
Temas de la conferencia
The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit has never been so crucial.
La Sociedad Científica
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1443975-3?pid=4832

Speakers: Adam Cockrell, Senior Director of Vector Biology, AavantiBio, Alex Murphy, Senior Medical Director, Roche, Beatrice Darimont, Chief Scientific Officer, Cytoo and More
 

Información e inscripción:

https://go.evvnt.com/1443975-2?pid=4832
Ms. Emily Birt
 
Categorías
Salud Pública, Servicios de salud
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5396.00
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

AMREF - African Medical and Research FoundationSwiss Tropical and Public Health InstituteHelix - Forschung & Beratung WiennewTreeAnästhesie in Entwicklungsländern e. V.Center of ExcellenceÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes Kreuz